Icon

TREXIMET (nda021926)- (60MG;EQ 10MG BASE,500MG;EQ 85MG BASE)

NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE CURRAX
60MG;EQ 10MG BASE,500MG;EQ 85MG BASE
Yes Yes
2026-Apr-02 Expired
None None
None No
TREXIMET is a combination of sumatriptan, a serotonin (5-HT) 1b/1d receptor agonist (triptan), and naproxen sodium, a non-steroidal anti-inflammatory drug, indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older.
3 2 2
Total Other Developers 2
Drugs with Suitability No
60MG;EQ 10MG BASE ** ** - - -
500MG;EQ 85MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.